Fab portion of dupilumab with Crystal Kappa design
External Resource: Annotation
| Chains | Family Name | Domain Identifier | Architecture | Possible Homology | Homology | Topology | Family | Provenance Source (Version) |
| B | C1-set_4 | e6wg8B2 | A: beta sandwiches | X: Immunoglobulin-like beta-sandwich | H: Immunoglobulin-related | T: Immunoglobulin/Fibronectin type III/E set domains/PapD-like | F: C1-set_4 | ECOD (1.6) |
| B | V-set | e6wg8B1 | A: beta sandwiches | X: Immunoglobulin-like beta-sandwich | H: Immunoglobulin-related | T: Immunoglobulin/Fibronectin type III/E set domains/PapD-like | F: V-set | ECOD (1.6) |
| A | C1-set_1 | e6wg8A2 | A: beta sandwiches | X: Immunoglobulin-like beta-sandwich | H: Immunoglobulin-related | T: Immunoglobulin/Fibronectin type III/E set domains/PapD-like | F: C1-set_1 | ECOD (1.6) |
| A | V-set_12 | e6wg8A1 | A: beta sandwiches | X: Immunoglobulin-like beta-sandwich | H: Immunoglobulin-related | T: Immunoglobulin/Fibronectin type III/E set domains/PapD-like | F: V-set_12 | ECOD (1.6) |
| Chain | Protein Name | Description | Organism Name | Gene Allele Name(s) | Domain Name(s) | Receptor Type | Receptor Description | Provenance Source |
|---|
| | Fab Dupilumab | L-KAPPA | Homo sapiens (human) | IGKV2-28*01, IGKV2D-28*01, IGKJ2*01, IGKC*01 | V-DOMAIN V-KAPPA, C-DOMAIN C-KAPPA | IG | FAB-GAMMA-4_KAPPA | IMGT (202542-0) |
| | Fab Dupilumab | VH-CH1 | Homo sapiens (human) | IGHV3-23*04, IGHJ6*01, IGHG4*01, IGHG4*04 | V-DOMAIN VH, C-DOMAIN CH1 | IG | FAB-GAMMA-4_KAPPA | IMGT (202542-0) |
| Chain | Chain Class | Chain Subclass | Chain Type | Antigen Name(s) | Provenance Source |
|---|
| | Light Chain | IGKV2 | Kappa | - | SAbDab (2025-10-31) |
| | Heavy Chain | IGHV3 | - | - | SAbDab (2025-10-31) |
| Chain | Name | Target | Provenance Source |
|---|
| Dupilumab | IL4R/CD124 | Therapeutic SAbDab (2025-10-31) |
| Dupilumab | IL4R/CD124 | Therapeutic SAbDab (2025-10-31) |